The percutaneous absorption rates and permeation kinetics of dermal exposure to methanol (67561) were examined. Sequential blood samples were collected from 12 volunteers before and after up to 16 minutes of hand immersion in methanol. A two compartment model representing the exposed skin and the rest of the body was used to determine permeation kinetics. Baseline methanol concentrations in the blood averaged 1.7+/-0.9 milligrams per liter (mg/l). The average baseline methanol concentration in females, 2.4+/-0.8mg/l, was significantly higher than that in males, 1.3+/-0.8mg/l. Baseline and maximum methanol concentrations varied considerably within and between subjects. The maximum methanol concentration in the blood exhibited a strong linear relationship with exposure duration. In females, the average maximum methanol concentration increased from 0.5+/-0.5mg/l with no exposure to 9.8+/-1.2mg/l with 16 minutes of exposure. In males, the average maximum methanol concentration increased from 1.0+/-0.7mg/l with no exposure to 12.5+/-2.2mg/l with 16 minutes of exposure. On average, maximum methanol concentrations were 24% higher in males than in females. Maximum methanol concentrations were sampled an average of 1.9+/-1.0 hours following exposure. The maximum methanol concentrations did not exhibit significant relationships with body weight or exposed skin area. The area under the curve was highly correlated with exposure duration and maximum methanol concentrations. Methanol delivery into the blood, which increased with exposure duration, peaked at 0.5 hours after exposure. The methanol absorption rate averaged 8.1+/-3.7 milligrams per centimeter per hour, regardless of exposure duration. The authors conclude that the above absorption and permeation rates may be useful in the biological monitoring and mathematical modeling of dermal methanol exposure.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.